Acarix AS Price To Book vs. Debt To Equity
| ACARIX Stock | SEK 0.31 0.01 3.33% |
For Acarix AS profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Acarix AS to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Acarix AS utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Acarix AS's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Acarix AS over time as well as its relative position and ranking within its peers.
Acarix |
Acarix AS Debt To Equity vs. Price To Book Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Acarix AS's current stock value. Our valuation model uses many indicators to compare Acarix AS value to that of its competitors to determine the firm's financial worth. Acarix AS is number one stock in price to book category among its peers. It also is number one stock in debt to equity category among its peers fabricating about 1.41 of Debt To Equity per Price To Book. Comparative valuation analysis is a catch-all model that can be used if you cannot value Acarix AS by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Acarix AS's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Acarix Debt To Equity vs. Price To Book
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Acarix AS |
| = | 1.63 X |
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Acarix AS |
| = | 2.30 % |
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
Acarix Debt To Equity Comparison
Acarix AS is currently under evaluation in debt to equity category among its peers.
Acarix AS Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Acarix AS, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Acarix AS will eventually generate negative long term returns. The profitability progress is the general direction of Acarix AS's change in net profit over the period of time. It can combine multiple indicators of Acarix AS, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Acarix AB , a medical technology company, develops and commercializes diagnostic tests for cardiovascular diseases primarily in Europe, China, and the United States. Acarix AB was founded in 2004 and is based in Malm, Sweden. Acarix AB operates under Medical Devices classification in Sweden and is traded on Stockholm Stock Exchange. It employs 11 people.
Acarix Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Acarix AS. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Acarix AS position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Acarix AS's important profitability drivers and their relationship over time.
Use Acarix AS in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Acarix AS position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acarix AS will appreciate offsetting losses from the drop in the long position's value.Acarix AS Pair Trading
Acarix AS Pair Trading Analysis
The ability to find closely correlated positions to Acarix AS could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Acarix AS when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Acarix AS - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Acarix AS to buy it.
The correlation of Acarix AS is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Acarix AS moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Acarix AS moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Acarix AS can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Acarix AS position
In addition to having Acarix AS in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Cannabis Thematic Idea Now
Cannabis
Equities that are involved in production and delivery of legal cannabis. This theme is designed for investors that are willing to accept higher levels of market risk inherited by cannabis production and distribution globally. The Cannabis theme has 30 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cannabis Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Acarix Stock
To fully project Acarix AS's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Acarix AS at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Acarix AS's income statement, its balance sheet, and the statement of cash flows.